[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352901-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352901-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","macrophage-derived-long-non-coding-rnas-in-cancer-pioneering-targets-for-immune-modulation-and-personalized-therapy","Macrophage-derived long non-coding RNAs in cancer - pioneering targets for immune modulation and personalized therapy","","Generated from macrophages, long non-coding RNAs (lncRNAs) are increasingly recognized as key regulators of cancer immune evasion, tumor microenvironment remodeling, and therapy sensitivity. This review examines how lncRNAs derived from M1 and M2 macrophage subtypes influence tumor progression. M2-associated lncRNAs are linked to enhanced proliferation, metastasis, and chemoresistance, whereas M1-derived lncRNAs support anti-tumor effects by strengthening inflammatory signaling and restricting epithelial-mesenchymal transition.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/macrophage-derived-long-non-coding-rnas-in-cancer-pioneering-targets-for-immune-modulation-and-personalized-therapy/352901/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/macrophage-derived-long-non-coding-rnas-in-cancer-pioneering-targets-for-immune-modulation-and-personalized-therapy/352901.png","ImageObject",300,407,{"name":42,"@type":43},"Rizky","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role do macrophage-derived long non-coding RNAs play in cancer?","Question",{"text":63,"@type":64},"They influence immune evasion, tumor microenvironment remodeling, and therapy sensitivity. The review emphasizes their regulatory functions in these processes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do M2-derived macrophage lncRNAs differ from M1-derived ones?",{"text":68,"@type":64},"M2-derived lncRNAs are associated with tumor-promoting activities such as proliferation, metastasis, and chemoresistance. M1-derived lncRNAs are linked to tumor-suppressive effects by enhancing inflammatory signals and limiting epithelial-mesenchymal transition.",{"name":70,"@type":61,"acceptedAnswer":71},"What recent research advances are highlighted for improving lncRNA targeting?",{"text":72,"@type":64},"The review points to progress in single-cell RNA sequencing and CRISPR-based functional studies, which can reveal new lncRNA targets and improve diagnostic accuracy and therapy optimization.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352901,1790671001,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","TYPE Review  \nPUBLISHED 28 April 2026  \nDOI 10.3389/fimmu.2026.1711686  \nOPEN ACCESS  \nEDITED BY  \nYanan Tan,  \nThe University of Hong Kong-Shenzhen Hospital, China  \nREVIEWED BY  \nAruna Pal,  \nWest Bengal University of Animal and  \nFishery Sciences, India Ashutosh Kumar, Ahmedabad University, India  \n*CORRESPONDENCE  \nSivakumar Arumugam  \n [siva_kumar.a@vit.ac.in](siva_kumar.a@vit.ac.in)  \nRECEIVED 23 September 2025  \nREVISED 11 April 2026  \nACCEPTED 14 April 2026  \nPUBLISHED 28 April 2026  \nCITATION  \nRamalingam PS, Hussain MS, Khan Y, Maqbool M, Agrawal M, Dh HS, Prabhu A, Ashique S, Kalra JM, Kalra K, Balakrishnan P and Arumugam S (2026) Macrophage-derived long non-coding RNAs in cancer: pioneering targets for immune modulation and personalized therapy.  \nFront. Immunol. 17:1711686 .  \ndoi: 10.3389/fimmu.2026.1711686  \nCOPYRIGHT  \n© 2026 Ramalingam, Hussain, Khan, Maqbool, Agrawal, Dh, Prabhu, Ashique, Kalra, Kalra, Balakrishnan and Arumugam. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMacrophage-derived long non-coding RNAs in cancer:  \npioneering targets for immune modulation and personalized therapy  \nPrasanna Srinivasan Ramalingam 1, Md Sadique Hussain 2, Yumna Khan 3, Mudasir Maqbool 4, Mohit Agrawal 5, Haleema Shahin Dh 6, Ashwini Prabhu 7, Sumel Ashique 8, Jyoti Maithani Kalra 9, Kapil Kalra 10,  \nPurushothaman Balakrishnan 11 and Sivakumar Arumugam 1*  \n1 Protein Engineering Lab, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India, 2 Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, Uttarakhand, India, 3 Independent Researcher, Abu Dhabi, United Arab Emirates,  \n4 Department of Pharmacology, Government Medical College Baramulla, Jammu and Kashmir, Baramulla, India, 5 Department of Pharmacology, School of Medical & Allied Sciences, K. R. Mangalam University, Gurugram, India, 6 Department of Pharmacology, Yenepoya Pharmacy College & Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India, 7 Division of Cell and Molecular Biology, Central Research Laboratory, Srinivas University, Mangalore, India, 8 Department of Pharmaceutical Technology, Bharat Technology, Howrah, West Bengal, India, 9School of Pharmaceutical Sciences, Shri Guru Ram Rai University, Dehradun, Uttarakhand, India, 10Alpine College of Management and Technology, Dehradun, Uttarakhand, India, 11TanBio R and D Solution, Thiruvarur, Tamil Nadu, India  \nGenerated from macrophages, long non-coding RNAs (lncRNAs) are increasingly recognized as imperative in inﬂuencing cancer immune evasion, microenvironment alteration, and therapy sensitivity. Together with tumor-associated macrophages (TAMs), this detailed investigation investigates the several roles of lncRNAs derived from M1 and M2 macrophage subtypes in regulating tumor progression. In contrast to the cancer-promoting effect of M2-based derived lncRNAs, such as H19, AFAP1-AS1, and CRNDE, which stimulate tumor proliferation, metastases, and chemoresistance through a variety of cascades, M1-based derived lncRNAs, such as HOTTIP and NBR2, exhibit tumor-suppressive roles in augmenting inﬂammatory signals and inhibiting epithelial-mesenchymal transition. Other than their involvement in the development of cancer, macrophage-derived lncRNAs have important immune control effects based on macrophage polarization, cytokine production, and immune checkpoints. Recent progress in singlecell RNA sequencing and the CRISPR-based functional studies also now provides new lncRNA targets and improved accuracy of diagnost","cbCaidyGnIm6w91e","https://ap.wps.com/l/cbCaidyGnIm6w91e","pdf",2780558,17,"English","# Introduction\n## Tumor microenvironment and immune interplay\n## Polarization of tumor-associated macrophages\n## M1 versus M2 macrophage-derived effects\n## Therapeutic implications","[{\"question\":\"What role do macrophage-derived long non-coding RNAs play in cancer?\",\"answer\":\"They influence immune evasion, tumor microenvironment remodeling, and therapy sensitivity. The review emphasizes their regulatory functions in these processes.\"},{\"question\":\"How do M2-derived macrophage lncRNAs differ from M1-derived ones?\",\"answer\":\"M2-derived lncRNAs are associated with tumor-promoting activities such as proliferation, metastasis, and chemoresistance. M1-derived lncRNAs are linked to tumor-suppressive effects by enhancing inflammatory signals and limiting epithelial-mesenchymal transition.\"},{\"question\":\"What recent research advances are highlighted for improving lncRNA targeting?\",\"answer\":\"The review points to progress in single-cell RNA sequencing and CRISPR-based functional studies, which can reveal new lncRNA targets and improve diagnostic accuracy and therapy optimization.\"}]","Macrophage-derived long non-coding RNAs in cancer - pioneering targets for immune modulation and personalized therapy | PDF",1790101941,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8168477013f229bce0bc91e3b4ec1af6.webp",983,1389,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d77969085ee5e44740482306f03e769f.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f7582cd67c32fc54142fe1f83d7b146.webp",981,1386,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db38c71a2f3017ccf3f0edfdf2bb181b.webp",980,1385]